813 results on '"Hölscher, Arnulf H"'
Search Results
252. The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC)
253. Ischemic Conditioning of the Gastric Conduit Prior to Esophagectomy Improves Mucosal Oxygen Saturation
254. Radiomorphology of the Habib Sealer-Induced Resection Plane during Long-Time Followup:A Longitudinal Single Center Experience after 64 Radiofrequency-AssistedLiver Resections
255. T2011 Identification of the Gnas1 T393c Polymorphism as a New Independent Prognostic Marker in Oesophageal Cancer
256. M1876 The Micro-RNA Profile of Responder and Non-Responder in the Neoadjuvant Therapy of Esophageal Cancer
257. S1941 GLUT-1 Expression in Gastric Cancer: A New Independent Prognostic Marker
258. T1639 Long-Term Outcome of Patients With Spontaneous Esophageal Rupture (Boerhaave's Syndrome) Undergoing Esophagectomy as the Definitive Treatment Strategy
259. Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer
260. [18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer
261. Early Gastric Cancer
262. Genetics in the Pathogenesis of Esophageal Cancer: Possible Predictive and Prognostic Factors
263. Closing the Loop Around Esophagectomy After Neoadjuvant Therapy
264. Quantitative analysis ofSurvivinRNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer
265. T1601 Prognostic Impact of ERCC1 Gene Polymorphisms in Gastric Cancer
266. T1846 Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Gene Expressions in Blood As Predictive Parameters for the Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer
267. M1753 Survivin Gene Expression in Blood As a Prognostic Marker in the Surgical Therapy of Patients with Esophageal Cancer
268. 1011 [18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemotherapy in Gastric Cancer
269. Improving Informed Consent of Surgical Patients Using a Multimedia-Based Program?
270. High Prevalence of Colonic Polyps in White Males with Esophageal Adenocarcinoma
271. Association of the GNAS1 T393C polymorphism with tumorstage and survival in gastric cancer
272. Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer
273. Extracapsular Lymph Node Involvement Differs Between Squamous Cell and Adenocarcinoma of the Esophagus
274. Strong Impact of Micrometastatic Tumor Cell Load in Patients with Esophageal Carcinoma
275. Improving Informed Consent of Surgical Patients Using a Multimedia-Based Program?
276. 951 High Expression of Heparanase Is Significantly Associated with Dedifferentiation and Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA and Via HIF1a to HB-EGF and bFGF
277. 948 The Role of ERCC1 RNA Expression in Blood As a Non-Invasive Predictor of Response to Neadjuvant Radio-Chemotherapy in Patients with Locally Advanced Cancer of the Esophagus
278. Which parameters are needed for targeting a multitined radiofrequency device—an approach to a simple algorithm
279. Re: Laparoscopic Ischemic Conditioning of the Stomach for Esophageal Replacement
280. Prevalence of Dysphagia in Patients with Gastroesophageal Reflux in Germany
281. Mindestmengen in der Viszeralchirurgie – was ist entscheidend: das Zentrum oder der einzelne Operateur?
282. Ösophaguskarzinom – da tut sich was!
283. Diaphragmatic Hernia After Conventional or Laparoscopic-Assisted Transthoracic Esophagectomy
284. Management of a traumatic aortoesophageal fistula in a patient with a right-sided aortic arch
285. Duodeno-Gastric-Esophageal Reflux—What is Pathologic? Comparison of Patients with Barrett’s Esophagus and Age-Matched Volunteers
286. Neoadjuvante und palliative Therapie des Ösophagus- und Magenkarzinoms
287. Die Therapie des Rektumkarzinoms
288. Epidemiologie, Diagnostik und Therapie des Barrett-Karzinoms.
289. Reduced Incidence of Nodal Micrometastasis after Major Response to Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer
290. Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
291. DNA Methyltransferases Messenger RNA Expression and Aberrant Methylation of CpG Islands in Non-Small-Cell Lung Cancer: Association and Prognostic Value
292. Sex Differences in the Predictive Power of the Molecular Prognostic Factor HER2/neu in Patients with Non–Small-Cell Lung Cancer
293. The prevention and management of perioperative complications
294. The Molecular Signature of Normal Squamous Esophageal Epithelium Identifies the Presence of a Field Effect and Can Discriminate between Patients with Barrett's Esophagus and Patients with Barrett's-Associated Adenocarcinoma
295. Giant adenomas of the rectum: complete resection by transanal endoscopic microsurgery (TEM)
296. Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes
297. Bile Reflux into the Stomach and the Esophagus for Volunteers Older than 40 Years
298. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus
299. MUC1 and Nuclear β-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis
300. Variability of Size and Shape of Necrosis Induced by Radiofrequency Ablation in Human Livers: A Volumetric Evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.